Minerva Neurosciences Inc (NERV)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $114.62M
Last updated: Nov 17, 2026 at 11:06 AM ET
Minerva Neurosciences Inc (NERV) Earnings: Report Dates and Results
Minerva Neurosciences (NERV) is expected to report earnings on Mar 9, 2027. In the quarter ended Sep 30, 2026, Minerva Neurosciences reported EPS of -$1.60. It beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
NERV has an expected report date of Mar 9, 2027.
Earnings History
Of the 37 quarters below that had an estimate, NERV beat 19, missed 17 and matched 1. The widest gap in the table came in the quarter ended Sep 30, 2024, when EPS landed 394.06% above the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$1.60 | -$0.14 | -$0.22 - -$0.14 | N/A | N/A | N/A | 2 | 1 up, 0 down | Nov 6, 2026 |
| Jun 30, 2026 | -$0.46 | -$0.01 | -$0.01 - -$0.01 | N/A | N/A | N/A | 1 | 1 up, 0 down | Aug 7, 2026 |
| Mar 31, 2026 | -$0.17 | -$0.14 | N/A | -23.19% | Miss | N/A | 1 | 1 up, 0 down | May 5, 2026 |
| Dec 31, 2025 | -$25.51 | -$0.30 | N/A | N/A | N/A | N/A | 1 | 0 up, 0 down | Mar 11, 2026 |
| Sep 30, 2025 | -$0.36 | -$0.35 | -$0.35 - -$0.35 | -2.86% | Miss | -112.1% | 1 | 0 up, 0 down | Nov 5, 2025 |
| Jun 30, 2025 | -$0.43 | -$0.90 | -$0.90 - -$0.90 | +52.22% | Beat | N/A | 1 | 0 up, 0 down | Aug 14, 2025 |
| Mar 31, 2025 | -$0.50 | -$1.07 | -$1.07 - -$1.07 | +53.27% | Beat | N/A | 1 | 0 up, 0 down | May 13, 2025 |
| Dec 31, 2024 | -$0.56 | -$1.05 | -$1.05 - -$1.05 | +46.67% | Beat | N/A | 1 | 0 up, 1 down | Feb 25, 2025 |
| Sep 30, 2024 | $2.97 | -$1.01 | -$1.01 - -$1.01 | +394.06% | Beat | N/A | 1 | 0 up, 0 down | Nov 5, 2024 |
| Jun 30, 2024 | -$1.09 | -$0.97 | -$0.97 - -$0.97 | -12.37% | Miss | N/A | 1 | 0 up, 0 down | Aug 6, 2024 |
| Mar 31, 2024 | -$1.13 | -$1.20 | -$1.20 - -$1.20 | +5.83% | Beat | N/A | 1 | 0 up, 0 down | May 1, 2024 |
| Dec 31, 2023 | -$1.39 | -$0.88 | N/A | -57.95% | Miss | N/A | N/A | 0 up, 0 down | Feb 22, 2024 |
| Sep 30, 2023 | -$1.03 | -$0.77 | -$0.77 - -$0.77 | -33.77% | Miss | N/A | 1 | 0 up, 0 down | Nov 7, 2023 |
| Jun 30, 2023 | -$1.12 | -$0.44 | -$0.44 - -$0.44 | -154.55% | Miss | N/A | 1 | 0 up, 0 down | Aug 1, 2023 |
| Mar 31, 2023 | -$1.31 | -$1.63 | -$1.63 - -$1.63 | +19.63% | Beat | N/A | 1 | 0 up, 0 down | May 15, 2023 |
| Dec 31, 2022 | -$1.26 | -$0.92 | -$1.35 - -$0.47 | -36.96% | Miss | N/A | 3 | 0 up, 0 down | Mar 8, 2023 |
| Sep 30, 2022 | -$1.29 | -$1.41 | -$1.88 - -$1.03 | +8.51% | Beat | N/A | 4 | 0 up, 0 down | Nov 9, 2022 |
| Jun 30, 2022 | -$1.63 | -$1.68 | -$1.84 - -$1.52 | +2.98% | Beat | N/A | 3 | 0 up, 0 down | Aug 9, 2022 |
| Mar 31, 2022 | -$1.84 | -$1.52 | -$1.76 - -$1.36 | -21.05% | Miss | N/A | 4 | 0 up, 0 down | May 4, 2022 |
| Dec 31, 2021 | -$4.00 | -$1.50 | -$1.68 - -$1.44 | -166.67% | Miss | N/A | 4 | 0 up, 0 down | Mar 1, 2022 |
| Sep 30, 2021 | -$1.76 | -$1.76 | -$2.08 - -$1.60 | 0.00% | In line | N/A | 4 | N/A | Nov 8, 2021 |
| Jun 30, 2021 | -$2.00 | -$1.39 | -$1.52 - -$1.20 | -43.88% | Miss | -134.2% | 5 | N/A | Aug 2, 2021 |
| Mar 31, 2021 | -$1.68 | $1.71 | -$1.44 - $9.60 | -198.25% | Miss | N/A | 5 | N/A | May 12, 2021 |
| Dec 31, 2020 | -$1.44 | -$1.53 | -$1.84 - -$1.20 | +5.88% | Beat | N/A | 6 | N/A | Mar 8, 2021 |
| Sep 30, 2020 | -$1.52 | -$1.83 | -$2.16 - -$1.60 | +16.94% | Beat | N/A | 6 | N/A | Nov 2, 2020 |
| Jun 30, 2020 | $5.84 | -$2.32 | -$2.48 - -$2.00 | +351.72% | Beat | N/A | 6 | N/A | Aug 3, 2020 |
| Mar 31, 2020 | -$2.48 | -$2.86 | -$3.28 - -$2.64 | +13.29% | Beat | N/A | 5 | N/A | May 4, 2020 |
| Dec 31, 2019 | -$6.16 | -$3.04 | -$3.92 - -$2.64 | -102.63% | Miss | N/A | 6 | N/A | Mar 9, 2020 |
| Sep 30, 2019 | -$2.88 | -$3.01 | -$3.76 - -$2.40 | +4.32% | Beat | N/A | 6 | N/A | Nov 4, 2019 |
| Jun 30, 2019 | -$2.56 | -$3.33 | -$3.36 - -$3.28 | +23.12% | Beat | N/A | 4 | N/A | Aug 5, 2019 |
| Mar 31, 2019 | -$3.28 | -$2.85 | -$2.88 - -$2.80 | -15.09% | Miss | N/A | 3 | N/A | May 6, 2019 |
| Dec 31, 2018 | -$2.72 | -$2.84 | -$3.04 - -$2.64 | +4.23% | Beat | N/A | 3 | N/A | Mar 12, 2019 |
| Sep 30, 2018 | -$2.48 | -$3.08 | -$3.12 - -$2.96 | +19.48% | Beat | N/A | 3 | N/A | Nov 5, 2018 |
| Jun 30, 2018 | -$2.56 | -$3.15 | -$3.20 - -$2.88 | +18.73% | Beat | N/A | 3 | N/A | Aug 2, 2018 |
| Mar 31, 2018 | -$2.56 | -$2.07 | N/A | -23.67% | Miss | N/A | 2 | N/A | May 3, 2018 |
| Dec 31, 2017 | -$1.92 | -$3.04 | -$3.44 - -$2.80 | +36.84% | Beat | N/A | 3 | N/A | Mar 12, 2018 |
| Sep 30, 2017 | -$2.24 | -$2.08 | -$2.16 - $4.16 | -7.69% | Miss | N/A | 3 | N/A | Nov 6, 2017 |
| Jun 30, 2017 | -$2.16 | -$2.56 | -$2.80 - -$2.56 | +15.63% | Beat | N/A | 2 | N/A | Aug 3, 2017 |
| Mar 31, 2017 | -$2.40 | -$2.24 | N/A | -7.14% | Miss | N/A | N/A | N/A | May 4, 2017 |
| Dec 31, 2016 | -$2.24 | -$2.00 | N/A | -12.00% | Miss | N/A | N/A | N/A | Mar 13, 2017 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$26.80, after $0.19 the year before. It was -$7.92 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$26.80 | -14205.3% |
| Dec 31, 2024 | $0.19 | N/A |
| Dec 31, 2023 | -$4.85 | N/A |
| Dec 31, 2022 | -$6.02 | N/A |
| Dec 31, 2021 | -$9.44 | -2460.0% |
| Dec 31, 2020 | $0.40 | N/A |
| Dec 31, 2019 | -$14.88 | N/A |
| Dec 31, 2018 | -$10.32 | N/A |
| Dec 31, 2017 | -$8.72 | N/A |
| Dec 31, 2016 | -$7.92 | N/A |
Frequently Asked Questions About NERV
When is Minerva Neurosciences's next earnings date?
Minerva Neurosciences's next earnings report is expected for Mar 9, 2027.
What EPS do analysts expect from NERV next quarter?
The consensus EPS estimate for Minerva Neurosciences for the quarter ending Dec 31, 2026 is -$0.14 from 5 analysts, with estimates from -$0.24 to -$0.01.
How often does NERV beat earnings estimates?
Minerva Neurosciences beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate, with an average surprise of +64.20%.
NERV pages: Overview, Earnings, Forecast, Financials, Competitors